Search research articles
Contact Us
Filters
Showing results (1-10 of 183) with videos related to
Page
of 19
Sort By:
Lancet (London, England)
|
May 28, 2026
Advancing tau-PET imaging in Alzheimer's disease
Joseph Therriault
Brain : a Journal of Neurology
|
June 16, 2023
Towards in vivo PET imaging of primary age-related tauopathy
Joseph Therriault, Michel J Grothe
Aging
|
September 14, 2022
<i>In vivo</i> tau staging in Alzheimer's disease
Joseph Therriault, Serge Gauthier, Pedro Rosa-Neto
Aging
|
January 9, 2023
Applications of Alzheimer's disease staging to clinical trials
Joseph Therriault, Serge Gauthier, Pedro Rosa-Neto
Handbook of Clinical Neurology
|
May 8, 2025
Cholinergic therapy in Alzheimer disease
Serge Gauthier, Joseph Therriault, Pedro Rosa-Neto
Expert Review of Neurotherapeutics
|
October 23, 2020
Impact of p-tau181 and p-tau217 levels on enrollment for randomized clinical trials and future use of anti-amyloid and anti-tau drugs
Serge Gauthier, Joseph Therriault, Tharick Pascoal, et al.
Neurology
|
January 31, 2022
Author Response: Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, <i>APOE</i> ε4, and Cognitive Impairment
Joseph Therriault, Tharick Pascoal, Serge Gauthier, et al.
European Neurology
|
August 2, 2021
The Role of Apolipoprotein E ε4 in Early and Late Mild Cognitive Impairment
Yulin Luo, Li Tan, Joseph Therriault, et al.
Journal of Integrative Neuroscience
|
July 14, 2021
Apolipoprotein E ε4 and ε3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-β in mild cognitive impairment but not in Alzheimer's disease
Feng Xing, Tao Meng, Joseph Therriault, et al.
Frontiers in Aging Neuroscience
|
May 14, 2021
The Effects of CSF Neurogranin and <i>APOE</i> ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer's Disease
Yulan Fan, Ying Gao, Joseph Therriault, et al.
Page
of 19
Search research articles
Search
Showing results (1-10 of 183) with videos related to
Sort By:
Page
of 19
Lancet (London, England)
|
May 28, 2026
Advancing tau-PET imaging in Alzheimer's disease
Joseph Therriault
Brain : a Journal of Neurology
|
June 16, 2023
Towards in vivo PET imaging of primary age-related tauopathy
Joseph Therriault, Michel J Grothe
Aging
|
September 14, 2022
<i>In vivo</i> tau staging in Alzheimer's disease
Joseph Therriault, Serge Gauthier, Pedro Rosa-Neto
Aging
|
January 9, 2023
Applications of Alzheimer's disease staging to clinical trials
Joseph Therriault, Serge Gauthier, Pedro Rosa-Neto
Handbook of Clinical Neurology
|
May 8, 2025
Cholinergic therapy in Alzheimer disease
Serge Gauthier, Joseph Therriault, Pedro Rosa-Neto
Expert Review of Neurotherapeutics
|
October 23, 2020
Impact of p-tau181 and p-tau217 levels on enrollment for randomized clinical trials and future use of anti-amyloid and anti-tau drugs
Serge Gauthier, Joseph Therriault, Tharick Pascoal, et al.
Neurology
|
January 31, 2022
Author Response: Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, <i>APOE</i> ε4, and Cognitive Impairment
Joseph Therriault, Tharick Pascoal, Serge Gauthier, et al.
European Neurology
|
August 2, 2021
The Role of Apolipoprotein E ε4 in Early and Late Mild Cognitive Impairment
Yulin Luo, Li Tan, Joseph Therriault, et al.
Journal of Integrative Neuroscience
|
July 14, 2021
Apolipoprotein E ε4 and ε3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-β in mild cognitive impairment but not in Alzheimer's disease
Feng Xing, Tao Meng, Joseph Therriault, et al.
Frontiers in Aging Neuroscience
|
May 14, 2021
The Effects of CSF Neurogranin and <i>APOE</i> ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer's Disease
Yulan Fan, Ying Gao, Joseph Therriault, et al.
Page
of 19